You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › March › 29
Rybelsus
15 months ago
The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart disease.
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years ○
The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart disease.
page 1 of 1